We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fischer and iCAD to Cooperate on CAD Mammography

By HospiMedica staff writers
Posted on 22 Jan 2003
An agreement to cooperate in adapting the computer-aided detection (CAD) technology of iCAD, Inc. (Hudson, NH, USA) for use in the analysis of the mammograms produced by the SenoScan digital mammography system of Fischer Imaging Corp. (Denver, CO, USA) was announced by the two companies at the annual meeting of the Radiological Society of North America (RSNA) in Chicago (IL, USA).

Under the agreement, Fischer will have worldwide exclusive rights to market this specialized iCAD software, designed to assist radiologists in identifying cancers that might otherwise be overlooked in routine mammography screening. Computer-aided detection from iCAD has been shown to detect 23% of breast cancers an average of 14 months earlier than screening mammography. ICAD says it is the fastest system available, is the only system to look for asymmetries, and is the most effective system available to detect breast masses.

"The SenoScan's industry-leading resolution of 50 microns in screening mode and 25 microns in diagnostic mode make it the ideal platform for iCAD's technology. We look forward to the results of this collaborative effort,” said Gerald D. Knudson, CEO of Fischer Imaging.





Related Links:
ICAD
Fischer Imaging
Adjustable Mobile Barrier
M-458
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Multi-Use Ultrasound Table
Clinton
High-Precision QA Tool
DEXA Phantom

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.